Related Experiment Video
Updated: May 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Implementing a statin switching programme in primary care: patients' views and experiences.
Janet Krska1, Katie Allison, Michela Delargy
1School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK. j.krska@kent.ac.uk
Many patients don't understand why their statin medication is switched, despite standard information. Improved communication, possibly involving community pharmacists, could enhance patient acceptance of therapeutic switching.
Area of Science:
- Pharmacoeconomics
- Patient Adherence
- Health Services Research
Background:
- Therapeutic switching of medicines is common for cost reduction, with standard methods promoted in England.
- Previous research indicates patient skepticism towards generic products and potential decreases in medication compliance.
- Patient perspectives on switching processes remain under-researched.
Purpose of the Study:
- To explore patient and pharmacist views on switching from atorvastatin to simvastatin in English primary care.
- To evaluate the effectiveness of standard communication methods used during medication switches.
Main Methods:
- Postal questionnaires were sent to patients switched from atorvastatin to simvastatin.
- Practice pharmacists involved in the switches were interviewed.
- Data collected included demographics, experiences, and views on the switching process.
Main Results:
- Over half of patients (52.9%) did not understand the reason for the statin switch, especially those with lower educational attainment.
- While many reported satisfaction with the switch and information received, a significant portion expressed dissatisfaction or lack of understanding.
- Patients preferred face-to-face consultations for future medication switches, with strong agreement on the role of community pharmacists in explaining changes.
Conclusions:
- Standardized medication switching processes may lead to suboptimal patient understanding and acceptance.
- Enhanced communication strategies, potentially including community pharmacist involvement, are needed to improve patient comprehension and adherence.
- Current methods for informing patients about therapeutic switches require improvement to ensure better outcomes.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina V: Nursing Management
Peripheral Artery Disease III: Interprofessional Care